Clinical Trials Browser

Phase 2 × Glioblastoma × Endostatins × Clear all

NCT04267978 2024-10-15

Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas

Phase 2 Recruiting

Glioblastoma, Recurrence